Cellebrite DI (CLBT) | Stock Overview & Key Data
Cellebrite DI Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $26.30 on February 3, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cellebrite DI
CLBT
|
3.18B Mid-cap | 11.65% | 3.96% | 3.20% | -21.22% | -20.52% | -11.69% | 157.97% | 48.79% | 52.48% | 52.48% | 52.48% |
|
Microsoft
MSFT
|
3.09T Mega-cap | 3.55% | 3.32% | 5.80% | -10.55% | -9.64% | -2.20% | 34.24% | 79.53% | 769.36% | 1,783.06% | 1,878.21% |
|
Oracle
ORCL
|
498.36B Mega-cap | 20.62% | 27.76% | 54.57% | 10.88% | 17.69% | 36.40% | 113.22% | 172.39% | 477.44% | 598.36% | 1,495.62% |
|
DigitalOcean
DOCN
|
9.90B Mid-cap | 15.46% | 59.62% | 213.50% | 278.47% | 254.67% | 451.06% | 276.33% | 289.19% | 274.61% | 274.61% | 274.61% |
|
Nutanix
NTNX
|
9.30B Mid-cap | 10.51% | 23.98% | 29.24% | 10.34% | 2.91% | -32.10% | 70.44% | 55.53% | 40.73% | 40.73% | 40.73% |
|
Informatica
INFA
|
7.64B Mid-cap | -0.24% | -0.24% | 0.20% | 27.52% | 50.70% | -5.96% | 42.96% | -16.42% | -16.42% | -16.42% | -16.42% |
Ownership & Short Interest
Calculate Your Cellebrite DI Investment Returns
Long-Term Investment Performance Analysis
Cellebrite DI stock price in Nov 2020 was $9.66, A $1,000.00 lump sum investment in Cellebrite DI made 5 years ago would be worth approximately $1,467.91 today, representing a positive return of 46.79%. This translates to an annualized return (CAGR) of 7.12%.
5 Years 7 Months Investment Scenario (Nov 2020 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is CLBT's 52-week high and low?
- In the last 52 weeks, Cellebrite DI reached a high of $19.98 (on November 13, 2025) and a low of $11.02 (on April 10, 2026).
- What is the market cap and P/E ratio for CLBT?
- Curious about Cellebrite DI's size and valuation? Its market capitalization stands at 3.18B. When it comes to valuation, the P/E ratio (trailing twelve months) is 42.90, and the forward P/E (looking ahead) is 21.80.
- Does CLBT pay dividends? If so, what's the yield?
- As for dividends, Cellebrite DI isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Cellebrite DI's main competitors or similar companies to consider before investing?
When looking at Cellebrite DI, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Microsoft
MSFT3.09T Technology Software - Infrastructure -2.20% 34.24% Oracle
ORCL498.36B Technology Software - Infrastructure 36.40% 113.22% DigitalOcean
DOCN9.90B Technology Software - Infrastructure 451.06% 276.33% Nutanix
NTNX9.30B Technology Software - Infrastructure -32.10% 70.44% Informatica
INFA7.64B Technology Software - Infrastructure -5.96% 42.96% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Cellebrite DI Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Cellebrite DI's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 19.10%, the Debt to Equity ratio from the most recent quarter is 4.68, and its Gross Profit Margin stands at 84.71%.
- What is the recent revenue and earnings growth for CLBT?
- Looking at Cellebrite DI's growth, its revenue over the trailing twelve months (TTM) was $476M. Compared to the same quarter last year (YoY), quarterly revenue grew by 18.10%, and quarterly earnings saw a YoY growth of 10.30%.
- How much of CLBT stock is held by insiders and institutions?
- Wondering who owns Cellebrite DI stock? Company insiders (like executives and directors) hold about 43.14% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 53.29%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.